Comments

cbdMD

Q: What sector and industry does cbdMD (YCBD) operate in?

cbdMD is in the Health Care sector and Pharmaceuticals industry. They are listed on the AMEX.

YCBDAMEX

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

15 minutes delayed

cbdMD (YCBD) Forecast

News Earnings Guidance Dividends Analyst Ratings Insider Trades Short Interest

cbdMD (AMEX:YCBD) Stock Quotes, Forecast and News Summary

cbdMD Stock (AMEX: YCBD) stock price, news, charts, stock research, profile.

Open	$0.50
Close	-
Volume / Avg.	18.00K / 35.27K
Day Range	$0.50 - $0.54
52 Wk Range	0.45 - 1.73
Market Cap	$1.94M
P/E Ratio	-
Dividend Yield	-
Exchange	AMEX
RSI	47
Short Interest	4.71%
Days to Cover	3.12

Recent News

cbdMD Reduces Operating Loss, Reports Positive Net Income For Q3 And 15% YoY Drop In Net Sales

cbdMD, Inc. (NYSE: YCBD), an operator of the leading CBD brands cbdMD and Paw CBD, along with its new functional mushroom brand ATRx Labs announced on Wednesday its financial results for the third quarter of fiscal 2024 ending June 30, 2024. Year-over-year, operational losses improved markedly, shrinking from $1.8 million in the third quarter of fiscal 2023 to $0.38 million in the third quarter of fiscal 2024, the company highlighted in the press release. Ronan Kennedy, the company's CEO and CFO, praised the financial results.

Jelena Martinovic

IM Cannabis, Organigram And Other Hot Cannabis Stocks Soon To Report Earnings, What Investors Need To Know Now

Medical cannabis company IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC), with operations in Israel and Germany, will report operational and financial results for the second quarter of 2024 ended June 30, 2024, on Wednesday, Aug. 14, 2024. cbdMD, Inc. (NYSE: YCBD) said it will host a conference call at 4:20 pm Eastern Time, on Wednesday, Aug. 14, 2024, to discuss the company's June 30, 2024 third quarter of fiscal 2024 financial results and business progress. Canadian cannabis producer and distributor Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) its second quarter 2024 financial results will be released after market close on Monday, Aug. 26, 2024. The company will host a conference call to discuss the results and provide an operational update and recap of achievements on Tuesday, Aug. 27, 2024. Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. will report earnings results for its third quarter fiscal 2024 ended June 30, 2024, on Tuesday, Aug. 13, 2024, before market open. The company will host a conference call to discuss its results with details the same day at 8:00 am Eastern Time.

Jelena Martinovic

cbdMD's Financial Results: Cost-Cutting Measures For Positive Cash Flow Amid Increasing Losses

cbdMD, Inc. (NYSE: YCBD) announced its financial results for the second quarter of fiscal 2024, ending March 31, 2024. Despite an increase in operational losses from $1.4 million in Q2 fiscal 2023 to $1.5 million in Q2 fiscal 2024, management remains optimistic.

Nicolás Jose Rodriguez

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About cbdMD Inc

Sector

Health Care

Industry

Pharmaceuticals

cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy cbdMD (YCBD) stock?

You can purchase shares of cbdMD (AMEX:YCBD) through any online brokerage.

View our list of the best stock brokerages

Who are cbdMD (YCBD) competitors?

Other companies in cbdMD’s space includes: NovaBay Pharmaceuticals (AMEX:NBY), 60 Degrees (NASDAQ:SXTP), Akanda (NASDAQ:AKAN), Sonoma Pharmaceuticals (NASDAQ:SNOA) and Virpax Pharmaceuticals (NASDAQ:VRPX).

What is the forecast, or price target, for cbdMD (YCBD) stock?

cbdMD has a consensus price target of $3.00.

What is the current price for cbdMD (YCBD)?

The stock price for cbdMD (AMEX: YCBD) is $0.5148 last updated September 16, 2024 at 4:00 PM EDT.

Does cbdMD (YCBD) pay a dividend?

There are no upcoming dividends for cbdMD.

When is cbdMD (AMEX:YCBD) reporting earnings?

cbdMD’s Q3 earnings are confirmed for Wednesday, August 14, 2024.

Is cbdMD (YCBD) going to split?

There is no upcoming split for cbdMD.

What sector and industry does cbdMD (YCBD) operate in?

cbdMD is in the Health Care sector and Pharmaceuticals industry. They are listed on the AMEX.

Get Our Top Trade Ideas Delivered Daily - 65% Off Now